Anaplastic lymphoma kinase rearrangement and response to crizotinib in pancreatic ductal adenocarcinoma

Richard Tuli; Simon Lo; Jaimie Koo; Michael Pishvaian; R. Joseph Bender; Emanuel Petricoin; Jonathan Brody; Nicholas Nissen

doi:10.1200/PO.17.00016

Anaplastic lymphoma kinase rearrangement and response to crizotinib in pancreatic ductal adenocarcinoma

Richard Tuli^*, Simon Lo, Jaimie Koo, Michael Pishvaian, R. Joseph Bender, Emanuel Petricoin, Jonathan Brody, Nicholas Nissen

^*Corresponding author for this work

Surgery

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	1-5
Number of pages	5
Journal	JCO Precision Oncology
Volume	2017
Issue number	1
DOIs	https://doi.org/10.1200/PO.17.00016
State	Published - 2017

Access to Document

10.1200/PO.17.00016

Cite this

@article{5dec9191ae514c7d91db304aa1636762,

title = "Anaplastic lymphoma kinase rearrangement and response to crizotinib in pancreatic ductal adenocarcinoma",

author = "Richard Tuli and Simon Lo and Jaimie Koo and Michael Pishvaian and {Joseph Bender}, R. and Emanuel Petricoin and Jonathan Brody and Nicholas Nissen",

year = "2017",

doi = "10.1200/PO.17.00016",

language = "English",

volume = "2017",

pages = "1--5",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Anaplastic lymphoma kinase rearrangement and response to crizotinib in pancreatic ductal adenocarcinoma

AU - Tuli, Richard

AU - Lo, Simon

AU - Koo, Jaimie

AU - Pishvaian, Michael

AU - Joseph Bender, R.

AU - Petricoin, Emanuel

AU - Brody, Jonathan

AU - Nissen, Nicholas

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85077482236&partnerID=8YFLogxK

U2 - 10.1200/PO.17.00016

DO - 10.1200/PO.17.00016

M3 - Article

AN - SCOPUS:85077482236

SN - 2473-4284

VL - 2017

SP - 1

EP - 5

JO - JCO Precision Oncology

JF - JCO Precision Oncology

IS - 1

ER -

Anaplastic lymphoma kinase rearrangement and response to crizotinib in pancreatic ductal adenocarcinoma

Access to Document

Fingerprint

Cite this